Safety Concerns Halt Depression Trials; Gen Z and Alcohol; Prescribing Benzos

(MedPage Today) -- Xenon Pharmaceuticals said it paused enrollment in its major depressive disorder and bipolar depression trials after unexpected neuropsychiatric adverse events emerged. Many mental health and suicide risk indicators among youth...